drugset
drugset / Trial / NCT00582088

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83

NCT00582088 ↗

Phase 2 Unknown 500 enrolled U.S. Army Medical Research and Development Command
NaSingle-groupOpen-labelPrevention

Summary

The study is designed to assess the safety and immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI GSD 205, as a booster vaccination.

Timeline

Start
2008-03
Primary completion
2021-06
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject VEE C-84 Vaccine 0.5 ml Subcutaneous

Indications

Venezuelan equine encephalitis